Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke

D. J. Meiklejohn, Mark Adrian Vickers, R. Dijkhuisen, Michael Greaves

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Background and Purpose-Homocysteine is a proposed causal risk factor for atherosclerosis, but this remains controversial. We measured fasting plasma homocysteine concentrations immediately after atherothrombotic stroke and in the convalescent period to investigate this controversy.

Methods-One hundred six patients (59 men and 47 women, mean age 57.2 [25 to 70] and 56.5 [26 to 69] years, respectively) were recruited within 24 hours of admission, and 82 patients were resampled at least 3 months later. Fasting total plasma homocysteine (tHcy) concentrations were measured by high-performance liquid chromatography.

Results-Median tHcy in the acute phase of stroke was not significantly higher than in matched control subjects (men 9.2 [range 4.4 to 22.8] versus 8.7 [4.9 to 20] mu mol/L, P=0.09, Mann-Whitney U test; women 8.1 [4.8 to 32.3] versus 7.6 [3.3 to 14.4] mu mol/L, P=0.58). Median plasma concentrations increased significantly in the convalescent period (from 8.5 [4.8 to 19.2] to 10.1 [4.3 to 31.5] mu mol/L, P<0.001, Wilcoxon signed rank test) and were then significantly higher than in control subjects in both men and women (P=0.03 and 0.05, respectively, Mann-Whitney U test). This did not appear to be explained by alteration in the known covariates red-cell folate, serum B-12, or creatinine concentrations.

Conclusions-Homocysteine concentrations are not elevated after recent atherothrombotic stroke but rise in the convalescent period. These data do not support the hypothesis that raised plasma homocysteine concentrations predate atherothrombotic stroke. Instead, they offer an explanation for the discrepancies between prospective and retrospective studies and suggest that elevated tHcy levels may be caused by the disease process itself.

Original languageEnglish
Pages (from-to)57-62
Number of pages5
JournalStroke
Volume32
Issue number1
Publication statusPublished - Jan 2001

Keywords

  • atherothrombotic stroke
  • homocysteine
  • METHYLENETETRAHYDROFOLATE REDUCTASE GENE
  • BETA-SYNTHASE DEFICIENCY
  • SERUM TOTAL HOMOCYSTEINE
  • CORONARY-ARTERY DISEASE
  • VASCULAR-DISEASE
  • MYOCARDIAL-INFARCTION
  • RISK FACTOR
  • COMMON MUTATION
  • HEART-DISEASE
  • ATHEROSCLEROSIS RISK

Cite this

Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. / Meiklejohn, D. J.; Vickers, Mark Adrian; Dijkhuisen, R.; Greaves, Michael.

In: Stroke, Vol. 32, No. 1, 01.2001, p. 57-62.

Research output: Contribution to journalArticle

Meiklejohn, DJ, Vickers, MA, Dijkhuisen, R & Greaves, M 2001, 'Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke' Stroke, vol. 32, no. 1, pp. 57-62.
Meiklejohn, D. J. ; Vickers, Mark Adrian ; Dijkhuisen, R. ; Greaves, Michael. / Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. In: Stroke. 2001 ; Vol. 32, No. 1. pp. 57-62.
@article{da1ead37c24840f8b7b36882689ada43,
title = "Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke",
abstract = "Background and Purpose-Homocysteine is a proposed causal risk factor for atherosclerosis, but this remains controversial. We measured fasting plasma homocysteine concentrations immediately after atherothrombotic stroke and in the convalescent period to investigate this controversy.Methods-One hundred six patients (59 men and 47 women, mean age 57.2 [25 to 70] and 56.5 [26 to 69] years, respectively) were recruited within 24 hours of admission, and 82 patients were resampled at least 3 months later. Fasting total plasma homocysteine (tHcy) concentrations were measured by high-performance liquid chromatography.Results-Median tHcy in the acute phase of stroke was not significantly higher than in matched control subjects (men 9.2 [range 4.4 to 22.8] versus 8.7 [4.9 to 20] mu mol/L, P=0.09, Mann-Whitney U test; women 8.1 [4.8 to 32.3] versus 7.6 [3.3 to 14.4] mu mol/L, P=0.58). Median plasma concentrations increased significantly in the convalescent period (from 8.5 [4.8 to 19.2] to 10.1 [4.3 to 31.5] mu mol/L, P<0.001, Wilcoxon signed rank test) and were then significantly higher than in control subjects in both men and women (P=0.03 and 0.05, respectively, Mann-Whitney U test). This did not appear to be explained by alteration in the known covariates red-cell folate, serum B-12, or creatinine concentrations.Conclusions-Homocysteine concentrations are not elevated after recent atherothrombotic stroke but rise in the convalescent period. These data do not support the hypothesis that raised plasma homocysteine concentrations predate atherothrombotic stroke. Instead, they offer an explanation for the discrepancies between prospective and retrospective studies and suggest that elevated tHcy levels may be caused by the disease process itself.",
keywords = "atherothrombotic stroke, homocysteine, METHYLENETETRAHYDROFOLATE REDUCTASE GENE, BETA-SYNTHASE DEFICIENCY, SERUM TOTAL HOMOCYSTEINE, CORONARY-ARTERY DISEASE, VASCULAR-DISEASE, MYOCARDIAL-INFARCTION, RISK FACTOR, COMMON MUTATION, HEART-DISEASE, ATHEROSCLEROSIS RISK",
author = "Meiklejohn, {D. J.} and Vickers, {Mark Adrian} and R. Dijkhuisen and Michael Greaves",
year = "2001",
month = "1",
language = "English",
volume = "32",
pages = "57--62",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke

AU - Meiklejohn, D. J.

AU - Vickers, Mark Adrian

AU - Dijkhuisen, R.

AU - Greaves, Michael

PY - 2001/1

Y1 - 2001/1

N2 - Background and Purpose-Homocysteine is a proposed causal risk factor for atherosclerosis, but this remains controversial. We measured fasting plasma homocysteine concentrations immediately after atherothrombotic stroke and in the convalescent period to investigate this controversy.Methods-One hundred six patients (59 men and 47 women, mean age 57.2 [25 to 70] and 56.5 [26 to 69] years, respectively) were recruited within 24 hours of admission, and 82 patients were resampled at least 3 months later. Fasting total plasma homocysteine (tHcy) concentrations were measured by high-performance liquid chromatography.Results-Median tHcy in the acute phase of stroke was not significantly higher than in matched control subjects (men 9.2 [range 4.4 to 22.8] versus 8.7 [4.9 to 20] mu mol/L, P=0.09, Mann-Whitney U test; women 8.1 [4.8 to 32.3] versus 7.6 [3.3 to 14.4] mu mol/L, P=0.58). Median plasma concentrations increased significantly in the convalescent period (from 8.5 [4.8 to 19.2] to 10.1 [4.3 to 31.5] mu mol/L, P<0.001, Wilcoxon signed rank test) and were then significantly higher than in control subjects in both men and women (P=0.03 and 0.05, respectively, Mann-Whitney U test). This did not appear to be explained by alteration in the known covariates red-cell folate, serum B-12, or creatinine concentrations.Conclusions-Homocysteine concentrations are not elevated after recent atherothrombotic stroke but rise in the convalescent period. These data do not support the hypothesis that raised plasma homocysteine concentrations predate atherothrombotic stroke. Instead, they offer an explanation for the discrepancies between prospective and retrospective studies and suggest that elevated tHcy levels may be caused by the disease process itself.

AB - Background and Purpose-Homocysteine is a proposed causal risk factor for atherosclerosis, but this remains controversial. We measured fasting plasma homocysteine concentrations immediately after atherothrombotic stroke and in the convalescent period to investigate this controversy.Methods-One hundred six patients (59 men and 47 women, mean age 57.2 [25 to 70] and 56.5 [26 to 69] years, respectively) were recruited within 24 hours of admission, and 82 patients were resampled at least 3 months later. Fasting total plasma homocysteine (tHcy) concentrations were measured by high-performance liquid chromatography.Results-Median tHcy in the acute phase of stroke was not significantly higher than in matched control subjects (men 9.2 [range 4.4 to 22.8] versus 8.7 [4.9 to 20] mu mol/L, P=0.09, Mann-Whitney U test; women 8.1 [4.8 to 32.3] versus 7.6 [3.3 to 14.4] mu mol/L, P=0.58). Median plasma concentrations increased significantly in the convalescent period (from 8.5 [4.8 to 19.2] to 10.1 [4.3 to 31.5] mu mol/L, P<0.001, Wilcoxon signed rank test) and were then significantly higher than in control subjects in both men and women (P=0.03 and 0.05, respectively, Mann-Whitney U test). This did not appear to be explained by alteration in the known covariates red-cell folate, serum B-12, or creatinine concentrations.Conclusions-Homocysteine concentrations are not elevated after recent atherothrombotic stroke but rise in the convalescent period. These data do not support the hypothesis that raised plasma homocysteine concentrations predate atherothrombotic stroke. Instead, they offer an explanation for the discrepancies between prospective and retrospective studies and suggest that elevated tHcy levels may be caused by the disease process itself.

KW - atherothrombotic stroke

KW - homocysteine

KW - METHYLENETETRAHYDROFOLATE REDUCTASE GENE

KW - BETA-SYNTHASE DEFICIENCY

KW - SERUM TOTAL HOMOCYSTEINE

KW - CORONARY-ARTERY DISEASE

KW - VASCULAR-DISEASE

KW - MYOCARDIAL-INFARCTION

KW - RISK FACTOR

KW - COMMON MUTATION

KW - HEART-DISEASE

KW - ATHEROSCLEROSIS RISK

M3 - Article

VL - 32

SP - 57

EP - 62

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 1

ER -